Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA expands approval of breast cancer drug Kisqali
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of the breakthrough drug
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It targets high-risk HR-positive, HER2-negative stage II and III patients to prevent recurrence.
Major New Drug Approval For Preventing Recurrence In Early Stage Breast Cancer Patients: Weighing The Risks & Benefits of Kisqali
The Food and Drug Administration (FDA) has just approved the drug Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) as treatment for people with HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence.
Novartis’ Kisqali receives FDA approval to reduce the risk of breast cancer recurrence
Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR-positive,
The American Journal of Managed Care
3d
FDA Approves Ribociclib for Early Breast Cancer Treatment With High Recurrence Rate
The FDA approved
ribociclib
(
Kisqali
) for adjuvant treatment of high-risk, hormone receptor-positive, HER2-negative early breast cancer. The FDA approved
ribociclib
(
Kisqali
) with an aromatase ...
pharmaphorum
2d
Lilly on alert as new Kisqali approval threatens Verzenio
Novartis' CDK4/6 inhibitor Kisqali has claimed a broad FDA approval in early breast cancer that could give it an edge over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Secret Service probing post
FCC chair denies Trump call
Cancels appearance w/ Duda
Boy kills bear, saves father
Families lose appeal
Ban called for in TX schools
To get a second moon
COVID, Wuhan market link
Hold campaign event in MI
Vows to remain in race
Joins Motion Picture Assn.
Overdose deaths drop in US
To visit US next week
PGA welcomes LIV players
Gun case sentencing delay
Retires after 17 seasons
EU warns Apple
Collapse hazard recall
FTC on privacy controls
160M euros to Ukraine
Brazil threatens daily fines
To receive Holbrooke award
Existing home sales drop
Israel strikes Hezbollah
Man charged for threats
Hails economic progress
Dow, S&P hit record highs
UN backs Palestine
NYC subway joyride arrest
Makes MLB history
Related topics
Breast cancer
Food and Drug Administration
Feedback